Company news
Arvinas, Inc. news in 2019
Arvinas, Inc.'s news releases, calls and decks from 2019, newest first.
Arvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference
November 26, 2019
Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
November 20, 2019
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
November 5, 2019
Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 3, 2019
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
October 22, 2019
Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit
October 16, 2019
Arvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological Disorders
October 1, 2019
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
September 30, 2019
Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants
June 3, 2019
Decks in 2019
- 2nd Annual Targeted Protein Degradation Summit (October 2019)
Conference · 31 slides · Oct 23, 2019